Aniling participates in BBQ2022
Last week, Aniling participated in the BBQ2022 organized by CataloniaBio & HealthTech. After the obliged pause due to the COVID-19 pandemic, the BBQ welcomed nearly 400 professionals looking to meet …
Aniling has participated in the “Matchmaking en Diagnóstico in Vitro: Un impulso a la cadena de valor en salud”
Aniling has participated in the “Matchmaking en Diagnóstico in Vitro: Un impulso a la cadena de valor en salud”. Llorenç Coll, CEO at Aniling, had the opportunity for pitching and …
Aniling has reached the CE Mark for GEUS-CLL
We are very proud to announce that Aniling has reached the CE Mark for our first product, GEUS-CLL, a first-in-class IVD medical device to support the diagnosis, prognosis, treatment selection …